Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous Lymphadenoma is a unique skin tumor with specific protein markers and common gene mutations that may cause continuous cell growth.

Platelet factor 4 slows down hair growth and could make hair loss treatments more effective if removed.

A genetic variant in the androgen receptor gene increases heart disease risk in women but not in men.

Clascoterone may be an effective topical treatment for hair loss.

Some cannabinoid derivatives may be more effective than current drugs at targeting proteins relevant to prostate cancer treatment.

Parsley contains compounds that might be good for treating hair loss.

A new treatment called SAMiRNA-AR68 increases hair count in people with hair loss, showing similar results to existing treatments but without side effects.

New compounds were made that are promising for prostate cancer therapy.

A new mutation linked to partial Androgen Insensitivity Syndrome and prostate cancer was found in a patient unhappy with their female gender assignment.

Dexamethasone increases the activity of androgen receptors in human skin cells, which may link it to certain types of hair loss.

No clear link between specific gene and hair loss in Mexican brothers.

Enobosarm may effectively treat androgen receptor-positive breast cancer with fewer side effects.

Understanding androgen receptors, oxidative stress, and inflammation is key to developing better skin disease treatments.

Certain interactions help prepare the androgen receptor for pairing and activation, which is important for its role in development and disease.

The study found that androgen receptors in skin cells mainly affect the focal adhesion pathway and control the caveolin-1 gene, with implications for new treatments for related diseases.

Understanding how androgens and their receptors work can lead to improved treatments for skin diseases.

A new genetic change causing early stop in the androgen receptor gene was found in a patient with androgen insensitivity syndrome.

PF-05314882 selectively activates androgen receptors without much effect on prostate and may help in prostate cancer treatment and hair loss prevention.

Scientists successfully created and analyzed the structure of a part of the human androgen receptor with specific modulators and a peptide to understand how it binds differently in various tissues.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Early hormones shape sex-specific differences in rat glands.

Scientists made a sensor that can detect a specific type of RNA related to androgen receptors quickly and accurately.

Fewer GGC sequences in the androgen receptor gene improve finasteride treatment for hair loss.

RU58841, an androgen receptor blocker, significantly increased hair density, thickness, and length in monkeys when applied topically daily for several months.

The androgen receptor's shape-changing ability helps it function but can lead to cancer treatment resistance.

Androgen receptors in the mouse brain may explain cognitive and mood changes in prostate cancer treatment.

Chromosomal differences affect how muscle cells respond to testosterone.

Drugs targeting the Androgen Receptor are effective for treating prostate cancer and other androgen-related conditions.

Androgens and androgen receptors are important for metabolic health, affecting how the body uses glucose and fats through mitochondrial function.